ASML: There Is More To Its Valuation Than Meets The Eye

ASML retains a Strong Buy rating, with management projecting FY 2026 revenue of €44.5B and a 56% gross margin, alongside demand visibility extending into 2030. TTM EBIT margin is 39% and ROE is 66%, both described as far above sector medians.

Analysis

The key investment question is whether long-dated demand visibility converts into durable orders and shipments, not whether ASML has a strong moat. For the next few weeks, guidance can support sentiment, but without market expectations or valuation data we cannot judge whether the shares have further room to re-rate. Over 1–3 months, order intake, backlog conversion, customer capex plans and any guidance changes are the useful checks. Over 6–18 months, High-NA adoption and the service stream from the installed base could support resilience; delays, export restrictions or weaker fab spending could instead expose the lumpiness of equipment revenue. China restrictions are a two-sided risk: they can constrain sales directly and alter global customer investment decisions. Treat management’s visibility horizon as an outlook, not a guarantee of firm, non-cancellable demand. The contrarian risk is that strong quality and margins are already reflected in expectations; absent valuation and consensus data, an outright add on the bullish narrative alone has poor-defined asymmetry.

Key Decisions for Investors

• Hold existing ASML exposure; avoid chasing a near-term rally based solely on the outlook. Consider adding in tranches after a pullback or after order/backlog data confirm conversion, rather than using an unsupported price target.
• Before increasing exposure, verify quarterly bookings, backlog quality and conversion timing, customer capex updates, China-related sales exposure, and whether gross-margin guidance is being maintained. These are the missing inputs that determine whether visibility is translating into earnings.
• Treat order cancellations or deferrals, a downward guidance revision, worsening export restrictions, or evidence of delayed High-NA adoption as thesis-falsifying signals; reassess promptly if any emerge.
• No options trade is warranted from this information alone: the catalyst direction is positive but valuation, implied volatility and near-term expectations are not supplied.